Resolve Staffing Announces Record Sales for the Second Quarter 2005
CINCINNATI, Aug. 15, 2005 (PRIMEZONE) -- Resolve Staffing, Inc. (OTCBB:RSFF) reported today revenues of $5.4 million for the second quarter ended June 30, 2005, an improvement of $5 million or 1,220% over revenues of $410,000 for the second quarter of 2004 and a 217% increase over revenues of $1.7 million for the first quarter of 2005.
MQ Associates, Inc. and MedQuest, Inc. Announce Extension of Consent Solicitations
ALPHARETTA, Ga., Aug. 15, 2005 (PRIMEZONE) -- MQ Associates, Inc. ("MQ Associates") and MedQuest, Inc. ("MedQuest" and, together with MQ Associates, the "Company") today announced that they are each extending the expiration date for the previously announced consent solicitations to seek certain amendments to (i) the outstanding 12-1/4% Senior Discount Notes due 2012 of MQ Associates (the "12-1/4% Notes") and the related indenture dated as of August 24, 2004, and (ii) the outstanding 11-7/8% Senior Subordinated Notes due 2012 (the "11-7/8% Notes" and, together with the 12-1/4% Notes, the "Notes") of MedQuest and the related indenture dated as of August 15, 2002.
SDG&E Customers to Receive More Than $40 Million in Reliant Settlement With California Parties
SAN DIEGO, Aug. 15, 2005 (PRIMEZONE) -- San Diego Gas & Electric (SDG&E) joined with other California parties today in announcing that they have reached a settlement with merchant generator Reliant for overcharges during the energy crisis of 2000-2001.
EYI Industries Retains AGORA Investor Relations
TORONTO, Aug. 15, 2005 (PRIMEZONE) -- EYI Industries, Inc. (OTCBB: EYII) (www.stopdrinkingpoison.com) is pleased to announce it has retained the services of AGORA Investor Relations Corp. ("AGORA") (http://www.agoracom.com) to provide investor relations services.
Business Consulting Group Unlimited
Audiostocks.Com Interviews Leading Executives
SAN DIEGO, Aug. 15, 2005 (PRIMEZONE) -- AudioStocks.com is pleased to announce that it has posted exclusive interviews from leading executives from the following companies on the www.AudioStocks.com website: Chembio Diagnostics (OTCBB:CEMI), Telzuit Medical Technologies, Inc/Taylor Madison(OTCBB:TMDN), and Essential Innovations Technology Corp (OTCBB:ESIV).
Oxford Media Acquires Creative Business Concepts, Inc.
IRVINE, Calif., Aug. 15, 2005 (PRIMEZONE) -- Oxford Media, Inc. (OTCBB:OXMI), a leading digital solutions company providing secure, high-quality distribution of digital video and Internet content today announced the acquisition of Creative Business Concepts, Inc. (CBC), a privately held company specializing in network security and systems integration.
Northrop Grumman Completes Update of Navy Group II E-2C Aircraft with Avionics Technology Upgrade
SAN DIEGO, Aug. 15, 2005 (PRIMEZONE) -- Northrop Grumman Corporation (NYSE:NOC) has successfully completed integration of its avionics technology upgrade with commercial hardware to update the fleet of Group II E-2C aircraft for the U.S. Navy.
Encore Partners with Geothermal Industry Veteran
LOS ANGELES, Aug. 15, 2005 (PRIMEZONE) -- Encore Clean Energy, Inc. (OTCBB:ECLN) is pleased to announce that it has signed a Letter of Intent with ThermaSource, Inc., a Geothermal Engineering Consulting company. ThermaSource is an internationally recognized geothermal technology firm run by energy veteran Louis Capuano.
Knightsbridge Tankers Limited -- Presentation
HAMILTON, Bermuda, Aug. 15, 2005 (PRIMEZONE) -- Knightsbridge Tankers Limited (VLCCF) advises that a Presentation of its Second Quarter 2005 results, that were released on August 12, 2005, is available on the Company's website at www.knightsbridgetankers.com and at the following link: http://hugin.info/132879/R/1006385/155222.pdf
WARRINGTON, Pa., Aug. 15, 2005 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), announces that it has received a preliminary communication from the U.S. Food and Drug Administration (FDA) indicating that the Company's previously submitted Response Letter is not considered complete at this time. The FDA notified Discovery that it will provide, later this week, its official written communication regarding select matters for which the FDA may be requesting additional information. The Company previously submitted its Response Letter to the FDA's Approvable Letter for Surfaxin(r) (lucinactant) for the prevention of Respiratory Distress Syndrome (RDS) in premature infants on July 29, 2005.
